Paul Tudor Jones Tudor Investment Corp
Paul Tudor Jones is the founder of Tudor Investment Corporation and a pioneering macro trader. He rose to prominence after navigating the 1987 market crash successfully and has since built a multi-strategy firm spanning global markets. Jones is widely associated with discretionary macro trading, risk management discipline, and high-profile philanthropic efforts in education and the environment.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$53.9M |
| 2 |
COUP
Coupa Software Incorporated
COUP
|
+$32.1M |
| 3 |
COWN
Cowen Inc. Class A Common Stock
COWN
|
+$27.8M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$20.1M |
| 5 |
M&T Bank
MTB
|
+$20.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Y
Alleghany Corp
Y
|
+$93.4M |
| 2 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
+$71.8M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$42.9M |
| 4 |
ZEN
ZENDESK INC
ZEN
|
+$42.3M |
| 5 |
TWTR
Twitter, Inc.
TWTR
|
+$41.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.01% |
| 2 | Financials | 11.75% |
| 3 | Industrials | 10.85% |
| 4 | Healthcare | 10.32% |
| 5 | Consumer Discretionary | 8.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1451
Garrett Motion
GTX
$4.82B
| $611K | 0.01% |
80,173
+42,041
| +110% | +$295K |
|
|
ZIMV
1452
DELISTED
ZimVie
ZIMV
| $608K | 0.01% |
65,052
+31,090
| +92% | +$272K |
|
|
CBL
1453
CBL Properties
CBL
$1.72B
| $606K | 0.01% |
26,254
+11,837
| +82% | +$319K |
|
1454
PUT
Canadian Natural Resources
CNQ
$104B
| $606K | 0.01% |
+21,800
| New | +$623K |
|
1455
Iovance Biotherapeutics
IOVA
$3.65B
| $605K | 0.01% |
94,629
+15,849
| +20% | +$124K |
|
|
GPMT
1456
Granite Point Mortgage Trust
GPMT
$52.5M
| $604K | 0.01% |
112,646
-18,069
| -14% | -$117K |
|
1457
PUT
Tyson Foods
TSN
$20.4B
| $604K | 0.01% |
9,700
+4,200
| +76% | +$273K |
|
1458
CALL
Commercial Metals
CMC
$7.18B
| $603K | 0.01% |
12,500
-5,300
| -30% | -$243K |
|
1459
CALL
DraftKings
DKNG
$12.9B
| $602K | 0.01% |
53,100
+34,600
| +187% | +$482K |
|
1460
CALL
W.P. Carey
WPC
$16.3B
| $602K | 0.01% |
7,862
-5,819
| -43% | -$437K |
|
1461
Atara Biotherapeutics
ATRA
$95M
| $601K | 0.01% |
7,331
-1,494
| -17% | -$156K |
|
1462
Nektar Therapeutics
NKTR
$2.52B
| $601K | 0.01% |
17,722
-82
| -0.5% | -$3.97K |
|
1463
iShares MSCI Taiwan ETF
EWT
$11.2B
| $599K | 0.01% |
+14,918
| New | +$664K |
|
1464
CALL
Kimberly-Clark
KMB
$37B
| $598K | 0.01% |
4,400
-4,200
| -49% | -$534K |
|
|
AVB
1465
CALL
DELISTED
AvalonBay Communities
AVB
| $597K | 0.01% |
3,700
-900
| -20% | -$153K |
|
|
FRC
1466
PUT
DELISTED
First Republic Bank
FRC
| $597K | 0.01% |
+4,900
| New | +$598K |
|
1467
PUT
Essex Property Trust
ESS
$18.9B
| $594K | 0.01% |
+2,800
| New | +$612K |
|
1468
Credit Acceptance
CACC
$6.26B
| $591K | 0.01% |
1,246
-1,107
| -47% | -$508K |
|
1469
CALL
Citizens Financial Group
CFG
$29.6B
| $591K | 0.01% |
15,000
-2,300
| -13% | -$89.8K |
|
1470
CALL
Yum! Brands
YUM
$42.9B
| $589K | 0.01% |
+4,600
| New | +$557K |
|
1471
PUT
Cintas
CTAS
$83B
| $587K | 0.01% |
+5,200
| New | +$562K |
|
1472
Murphy USA
MUSA
$10.4B
| $587K | 0.01% |
2,100
-27,999
| -93% | -$8.12M |
|
|
MLNK
1473
DELISTED
MeridianLink
MLNK
| $585K | 0.01% |
42,591
+15,756
| +59% | +$243K |
|
1474
Sunstone Hotel Investors
SHO
$2.1B
| $585K | 0.01% |
60,601
-75,462
| -55% | -$780K |
|
|
BFS
1475
Saul Centers
BFS
$844M
| $583K | 0.01% |
14,340
+4,314
| +43% | +$175K |
|
Similar funds
Paul Tudor Jones's Q4 2022 Portfolio in Review
As of Q4 2022, Paul Tudor Jones held 3,056 positions worth $5.06B, up 9.2% from $4.63B the previous quarter. Its ten largest holdings account for 9.1% of the portfolio.
Paul Tudor Jones deployed $198M of net new capital in Q4 2022, opening 801 new positions and adding to 766 existing holdings. Its largest new stake was Horizon Therapeutics Public Limited Company Ordinary Shares: 648,672 shares worth $73.8M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 16% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was iShares MSCI Emerging Markets ETF, an estimated $39M trimmed.
- Paul Tudor Jones's largest Q4 2022 buy was Horizon Therapeutics Public Limited Company Ordinary Shares: 648,672 shares worth $73.8M.
- Paul Tudor Jones added most to Coupa Software Incorporated in Q4 2022, an estimated $32.1M increase.
- Paul Tudor Jones's biggest Q4 2022 reduction was iShares MSCI Emerging Markets ETF, cutting an estimated $39M.
- Paul Tudor Jones fully exited Alleghany Corp in Q4 2022, selling an estimated $93.4M.
- Paul Tudor Jones's ten largest holdings make up 9.1% of its $5.06B portfolio in Q4 2022.
- Paul Tudor Jones opened 801 new positions and closed 756 in Q4 2022.
- Paul Tudor Jones's portfolio value rose 9.2% quarter-over-quarter to $5.06B.
Based on Tudor Investment Corp's 13F filing for Q4 2022, filed 14 Feb 2023.